Slightly increased risk of meningioma with certain contraceptives containing desogestrel and etonogestrel
In July 2026, the Pharmacovigilance Risk Assessment Committee (PRAC) recommended adding the risk of meningioma to the package leaflet and to the summary of product characteristics (SmPC) of contraceptives containing desogestrel and etonogestrel.
Read the original at the source: https://gouvernement.lu/en/actualites/toutes_actualites/communiques/2026/09-septembre/24-sant-meningiome.html
Officially imported this from Government of Luxembourg’s own source. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Government of Luxembourg — imported from official source
- Official source
- https://gouvernement.lu/en/actualites/toutes_actualites.rss RSS
- Imported
- October 03, 2026 20:37
- Versions
- 1 recorded
- Identity
//gouvernement.lu/en/actualites/toutes_actualites/communiques/2026/09-septembre/24-sant...